<DOC>
	<DOCNO>NCT02099682</DOCNO>
	<brief_summary>The purpose study investigate safety efficacy long-term administration lansoprazole ( Takepron ) 12 month routine clinical setting patient receive low-dose aspirin</brief_summary>
	<brief_title>Long-term Use Takepron Capsules Prevention Recurrence Gastric/Duodenal Ulcer Patients Receiving Low-dose Aspirin</brief_title>
	<detailed_description>This special survey long-term use ( 12 month ) lansoprazole ( Takepron ) determine incidence adverse drug reaction routine clinical setting patient receive low-dose aspirin . The usual adult dosage 15 mg lansoprazole administer orally daily .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>( 1 ) Patients history gastric duodenal ulcer ( 2 ) Patients require longterm use lowdose aspirin ( 81324 mg daily ) prophylaxis thromboembolism ( 3 ) Patients take lowdose oral aspirin ( 81324 mg daily ) start administration lansoprazole ( include patient start lowdose aspirin day start administration lansoprazole ) ( 1 ) Patients gastric duodenal ulcer ( active [ A1 , A2 ] heal [ H1 , H2 ] stage assess endoscopically ) start administration lansoprazole ( 2 ) Patients active upper gastrointestinal hemorrhage start administration lansoprazole ( 3 ) Patients contraindication lansoprazole</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Pharmacological therapy</keyword>
</DOC>